Algorae Pharmaceuticals Limited has released a press release.
1AI commences AI-168 pre-clinical studies
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Addendum to September Quarterly Report
- CSIRO Grant for Artificial Intelligence Platform
- Quarterly Activities/Appendix 5B Cash Flow Report
- LCT commences AI-116 pre clinical studies
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from Algorae Pharmaceuticals
- Algorae to list existing Option series on ASX
- Agreement with HL Pharma Addendum
- Quarterly Activities Report/Appendix 4C Cash Flow Statement
- NTCELL Project Update
- Response to ASX Price Query
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals